Skip to content
Open access

Transcriptomic Profiling Reveals METTL26 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma with Independent Validation in Oral Squamous Cell Carcinoma

Oct 2026 · Medical Science · Vol 14 · 0 citations · 36 references
Medicine

TL;DR

In contrast, the observed associations with pathological stage, mitochondrial and redox-related programs, stromal composition, and therapy-response-related genes should be considered exploratory and hypothesis-generating and require independent and functional validation.

Abstract

Background: Methyltransferase-like 26 (METTL26) is a poorly characterized member of the METTL family that has been included in previous pan-cancer analyses, but its disease-specific clinical and molecular relevance in head and neck squamous cell carcinoma (HNSCC) and oral squamous cell carcinoma (OSCC) remains poorly defined. The aim of this study was to investigate METTL26 expression and its potential clinical and biological relevance in HNSCC, with particular attention to OSCC. Methods: The TCGA-HNSC dataset was used as a discovery dataset. METTL26 expression and pathological stage were evaluated using GEPIA3, whereas survival associations were analyzed in R. Tumor microenvironment associations were investigated using TIMER3. Genes co-expressed with METTL26 were subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses, while protein interaction networks were explored using STRING. These discovery analyses were performed using the heterogeneous TCGA-HNSC cohort, whereas two independent OSCC cohorts (GSE37991 and GSE30784) were primarily used to validate differential expression. Results: METTL26 expression was significantly increased in TCGA-HNSC compared to normal tissues and was associated with pathological stage. High METTL26 expression showed a non-significant trend toward poorer OS and PFI and was not independently associated with either outcome after multivariable adjustment. A positive association with cancer-associated fibroblast (CAF) abundance was detected using TIDE, whereas an inverse association with endothelial cell abundance was observed across multiple algorithms. Functional analysis showed enrichment of mitochondrial gene expression, mitochondrial translation, ribosomal functions, oxidative phosphorylation, and reactive oxygen species-related pathways. METTL26 was also positively correlated with several genes involved in therapy response such as PTOV1, MIF, BAD, and EIF3C. Importantly, METTL26 upregulation was independently confirmed in both OSCC cohorts, GSE37991 and GSE30784. Conclusions: METTL26 upregulation was independently confirmed in two OSCC cohorts, supporting its potential relevance as an expression biomarker. In contrast, the observed associations with pathological stage, mitochondrial and redox-related programs, stromal composition, and therapy-response-related genes should be considered exploratory and hypothesis-generating and require independent and functional validation.

Read PDF

Similar papers

Oct 2026

Integrated genomic and transcriptomic profiling identifies PFKM as a candidate biomarker of nodal metastasis in oral squamous cell carcinoma.

OBJECTIVES Nodal metastasis is a key prognostic determinant in oral squamous cell carcinoma (OSCC), yet its underlying molecular basis remains poorly defined. This study aimed to identify prognostic genes and pathways associated with nodal metastasis in OSCC using integrated genomic, transcriptomic, and experimental ap...

S. Kuk, Jae-Han Lee, Hyun-Ji Kim et al. · 0 citations
Open access Oct 2026

An Eight-Gene Metabolic Prognostic Signature in Head and Neck Squamous Cell Carcinoma: Cross-Cohort Evaluation, Single-Cell Analysis, and Preliminary Functional Evaluation of PYGL and G6PD

Background Head and neck squamous cell carcinoma (HNSCC) is the most prevalent pathological subtype of head and neck malignancies. Although metabolic reprogramming contributes to malignant progression and adaptation within the tumor microenvironment in HNSCC, its biological and prognostic implications remain incomplete...

Wan-Yi Kou, Rui-Xin Guo, Yi-Fan Zhang et al. · 1 citation
Oct 2026

Integrative bioinformatics analyses reveal LINC02269 and LINC01913 as potential prognostic biomarkers in head and neck squamous cell carcinoma

Head and Neck Squamous Cell Carcinoma (HNSCC) is a well-known cancer of the aerodigestive tract withlimited treatment options. Several studies have highlighted long non-coding RNAs (lncRNAs) as important regulatory moleculesand their dysregulation is linked to various diseases, including cancer. Here, we analysed RNA-S...

Rahul Kumar Singh, Shweta Pandey, G. Pandey · 0 citations
Open access Oct 2026

Pan-cancer and experimental analyses reveal TTC39B as a suppressor of cell proliferation in clear cell renal cell carcinoma

Tetratricopeptide repeat domain protein 39B (TTC39B) is a lipid metabolism–related gene recently implicated in cholesterol regulation. However, its clinical and biological relevance in human cancers remains undefined. Based on multi-omics data from the Cancer Genome Atlas (TCGA) pan-cancer dataset represen...

Hui-Juan Yi, Yan Wang, Chen-Hao Zhao et al. · 0 citations
Open access Oct 2026

Identification and Clinical Significance of Differentially Expressed Genes in the Tumour Microenvironment of Clear Cell Renal Cell Carcinoma.

OBJECTIVE To perform a bioinformatics analysis of differentially expressed genes (DEGs) in clear cell renal cell carcinoma (ccRCC), evaluate their clinical significance, and identify potential therapeutic targets for ccRCC. STUDY DESIGN An analytical study. Place and Duration of the Study: Department of Clinical Medi...

Rui Yang, Yan-Yan Guo · 0 citations
Jul 2026

Identification and characterization of shared transcriptomic signatures in BRCA2-mutated metastatic breast cancer and lung adenocarcinoma: An integrative bioinformatics approach.

Breast cancer and lung adenocarcinoma (LUAD) are most prevalent forms of malignancies worldwide and are associated with BRCA2 variants. While BRCA2 pathogenic variants are well established in breast cancer, their transcriptional consequences in lung adenocarcinoma remain poorly characterized, and no study has directly...

Emmania Abid, Saima Bilal, Mariam Shahid et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.